Miglitol tablets and acarbose generally do not have which one is better, need to be decided by a professional doctor according to the condition of the medication.
1. Miglitol tablets: a new type of α-glucosidase inhibitor, can effectively delay the absorption of glucose in the small intestine, generally does not lead to hypoglycemia, for patients with type 2 diabetes mellitus who have poor postprandial blood glucose control. If there are adverse reactions such as diarrhea, consult a doctor promptly.
2. Acarbose: It can inhibit the activity of α-glucosidase in the intestine, so that the degradation of oligosaccharides, polysaccharides or disaccharides in the intestine is delayed, and the degradation and absorption of glucose from carbohydrates to the blood is slowed down, and the fluctuation of blood glucose throughout the day is reduced. However, it is forbidden for people with severe liver and kidney insufficiency and diabetic ketoacidosis.
If you are not feeling well, go to regular hospitals for diagnosis and treatment, and do not increase or decrease the dosage of medication on your own to avoid adverse reactions.